ELYPTA
Elypta is developing a metabolism-based liquid biopsy platform based on a new IVD laboratory assay kit and artificial intelligence algorithms trained by their clinical database. Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment response. They also explore several other indications to understand the full potential for Elypta’s platform.
ELYPTA
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2017-05-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.elypta.com
Total Employee:
11+
Status:
Active
Contact:
+46 0 852 027 885
Email Addresses:
[email protected]
Total Funding:
32.62 M USD
Technology used in webpage:
Domain Not Resolving Pound Sterling 3 To 9 CcTLD Redirects OLM Amazon Stockholm Region
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
Navigare Ventures
Navigare Ventures investment in Series A - Elypta
Hillclimber
Hillclimber investment in Series A - Elypta
Nina Capital
Nina Capital investment in Series A - Elypta
Chalmers Ventures AB
Chalmers Ventures AB investment in Series A - Elypta
Norrsken VC
Norrsken VC investment in Series A - Elypta
Industrifonden
Industrifonden investment in Series A - Elypta
Bonnier Ventures
Bonnier Ventures investment in Series A - Elypta
Sciety
Sciety investment in Seed Round - Elypta
Chalmers Ventures AB
Chalmers Ventures AB investment in Seed Round - Elypta
Norrsken VC
Norrsken VC investment in Seed Round - Elypta
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-10 | Elypta appoints Volker Liebenberg as CMO |
Official Site Inspections
http://www.elypta.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Elypta"
Elypta - Crunchbase Company Profile & Funding
Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment …See details»
Elypta – Advancing Cancer Detection
Elypta raises $21 million Series A to develop metabolism-based multi-cancer early detection test. Jun 20, 2022. Elypta launches Multi-Cancer Early Detection screening study measuring …See details»
Francesco Gatto, Founder, Chief Scientific Officer, …
Francesco founded Elypta with his Ph.D. advisor Jens Nielsen in 2017 after spearheading the early entrepreneurial activities as interim CEO in 2015. As Chief Scientific Officer and deputy CEO, he is broadly responsible for the technical …See details»
Elypta Company Profile 2024: Valuation, Funding & Investors
Elypta General Information Description. Developer a metabolism-based liquid biopsy platform designed to prevent cancer mortality through earlier detection and closer monitoring. The …See details»
Elypta - LinkedIn
Elypta | 3,092 followers on LinkedIn. Advancing cancer detection | Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is ...See details»
Elypta – The Roddenberry Prize
Francesco founded Elypta with his Ph.D. advisor Jens Nielsen in 2017, oversees the technical plan, and leads all scientific projects at Elypta, acting as deputy CEO. A recipient of the Karin Markides Prize, the National SKAPA Innovation …See details»
Elypta Company Profile - Office Locations, Competitors, Revenue …
Elypta has 5 employees at their 1 location and $11.35 m in total funding,. See insights on Elypta including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Elypta - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Pre Seed Round - Elypta . 1: …See details»
Elypta - VentureRadar
Elypta’s liquid biopsy platform is based on the measurement and analysis of 20 metabolites; glycosaminoclycans; tracking a vital process in cancer. Machine learning is used to define and …See details»
Elypta - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Elypta . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Elypta – Industrifonden
Elypta is a diagnostics firm pioneering metabolism-based liquid biopsies. Its technology allows for non-invasive, safe, and cost-effective tests needed for early cancer diagnoses and for …See details»
Elypta's Liquid Biopsy Could Improve Accuracy of Cancer Diagnoses
Jun 22, 2018 Elypta is developing liquid biopsies that analyze cancer metabolism to make cancer diagnoses more accurate. Philip talked to Francesco Gatto, Elypta’s Chief Scientific …See details»
Elypta raises $21 million Series A to develop metabolism-based …
Jun 20, 2022 - The series A is a pivotal moment for Elypta as it fully funds the development of our two leading indications, says Karl Bergman, CEO at Elypta. The company will use the …See details»
Elypta, a Swedish company using metabolism-based liquid biopsy …
Stockholm, May 7, 2024: Elypta, a Swedish cancer detection company aiming to commercialize the first metabolism-based liquid biopsy for early detection of cancer, today announced the …See details»
Apply - Elypta
Organization. Research institute affiliation required for sponsorship application. Information about samples to be analysed. Number of samples * Approx. count also acceptable (10s or 100s or …See details»
Elypta - Chalmers Ventures
Elypta is developing an exceptionally sensitive liquid biopsy platform for early detection and monitoring of cancer. Elypta’s assay kit enables the measurement of a novel panel of …See details»
Team - Elypta
Elypta AB, Scheeles väg 3, 171 65 Solna, Sweden +46 (0)8 520 27 885 [email protected]. Science MIRAM® Kit Clinical Studies News Team Careers Contact. ISO 13485:2016 ...See details»
Elypta – Elypta raises $21 million Series A to develop metabolism …
Stockholm, June 20, 2022: Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early detection of any cancer, today announced the …See details»
News - Elypta
Elypta interim study results show glycosaminoglycan's potential to predict the risk of developing any-type cancer with a simple urine test. Jul 5, 2023. Elypta Receives ISO 13485:2016 Quality …See details»